Medicare Advantage insurers leaving certain markets affected more than 1 in 10 Americans enrolled in such plans with prescription drug coverage, a KFF analysis shows.
To date, every court that has considered substantive challenges to the Medicare drug price negotiation program has ruled against the pharmaceutical industry, dismissing both constitutional and ...
The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...
Objective: To determine whether industry payments to cardiologists are associated with Medicare beneficiary spending, as financial incentives may influence clinical deci ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results